Royalty Pharma plc

RPRX

$48.36

Name : Royalty Pharma plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $27,971,813,376.00

EPSttm : 1.78

Royalty Pharma plc

$48.36

0.81%

$0.39

RPRX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.92

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

0.9

EPS Last/This Y

3.27

EPS This/Next Y

0.39

Price

47.97

Target Price

52.43

Analyst Recom

1.5

Performance Q

22.75

Upside

-18.4%

Beta

0.39

Ticker: RPRX

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	RPRX	47.47	0.53	0.00	13205
2026-03-03	RPRX	47.48	0.51	0.00	13425
2026-03-04	RPRX	47.42	0.51	0.05	13499
2026-03-05	RPRX	45.69	0.51	0.10	13507
2026-03-06	RPRX	45.42	0.51	0.00	13529
2026-03-09	RPRX	45.82	0.51	0.00	13536
2026-03-10	RPRX	45.97	0.47	0.00	14114
2026-03-11	RPRX	46.69	0.47	0.00	14123
2026-03-12	RPRX	45.88	0.45	0.02	14516
2026-03-13	RPRX	45.87	0.45	0.02	14516
2026-03-17	RPRX	46.12	0.45	0.00	14568
2026-03-18	RPRX	45.8	0.45	3.00	14598
2026-03-19	RPRX	45.53	0.45	0.00	14587
2026-03-20	RPRX	45.37	0.45	0.00	14589
2026-03-23	RPRX	45.6	0.46	0.00	14245
2026-03-24	RPRX	45.56	0.46	0.00	14304
2026-03-25	RPRX	47.04	0.46	0.02	14314
2026-03-26	RPRX	46.92	0.46	0.00	14315
2026-03-27	RPRX	46.36	0.45	0.12	14445
2026-03-30	RPRX	46.36	0.45	0.02	14450
2026-03-31	RPRX	47.96	0.45	0.12	14604
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	RPRX	47.47	16.3	838.5	5.03
2026-03-03	RPRX	47.47	14.4	790.7	5.06
2026-03-04	RPRX	47.42	14.4	788.5	5.06
2026-03-05	RPRX	45.70	14.4	725.8	5.06
2026-03-06	RPRX	45.42	14.4	779.7	5.06
2026-03-09	RPRX	45.83	14.4	797.2	5.06
2026-03-10	RPRX	45.97	14.4	786.6	5.06
2026-03-11	RPRX	46.69	14.4	808.7	5.06
2026-03-12	RPRX	45.88	14.4	751.0	5.06
2026-03-13	RPRX	45.64	14.4	772.5	5.06
2026-03-17	RPRX	46.12	14.4	782.1	5.06
2026-03-18	RPRX	45.80	14.4	769.5	5.06
2026-03-19	RPRX	45.53	14.4	124.7	5.06
2026-03-20	RPRX	45.36	14.4	127.3	5.06
2026-03-23	RPRX	45.60	14.4	138.7	5.06
2026-03-24	RPRX	45.56	14.4	130.8	5.06
2026-03-25	RPRX	47.03	14.4	173.9	5.06
2026-03-26	RPRX	46.93	14.4	129.4	5.06
2026-03-27	RPRX	46.35	14.4	116.2	5.06
2026-03-30	RPRX	46.35	14.4	132.5	5.06
2026-03-31	RPRX	47.97	14.4	176.9	5.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	RPRX	-2.96	3.95	3.39
2026-03-03	RPRX	-2.96	3.95	3.39
2026-03-04	RPRX	-3.04	3.95	3.39
2026-03-05	RPRX	-3.04	3.95	3.39
2026-03-06	RPRX	-3.04	3.95	3.39
2026-03-09	RPRX	-3.04	3.92	3.39
2026-03-10	RPRX	-3.04	3.92	3.39
2026-03-11	RPRX	-3.04	3.92	3.06
2026-03-12	RPRX	-3.04	3.92	3.06
2026-03-13	RPRX	-3.04	3.92	3.06
2026-03-17	RPRX	-3.04	3.90	3.06
2026-03-18	RPRX	-3.04	3.90	3.06
2026-03-19	RPRX	-3.04	3.90	3.06
2026-03-20	RPRX	-3.04	3.90	3.06
2026-03-23	RPRX	-3.04	3.92	3.06
2026-03-24	RPRX	-3.04	3.92	3.06
2026-03-25	RPRX	-3.12	3.92	2.92
2026-03-26	RPRX	-3.12	3.92	2.92
2026-03-27	RPRX	-3.12	3.92	2.92
2026-03-30	RPRX	-3.12	3.92	2.92
2026-03-31	RPRX	-3.12	3.92	2.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.38

Avg. EPS Est. Current Quarter

1.21

Avg. EPS Est. Next Quarter

1.28

Insider Transactions

-3.12

Institutional Transactions

3.92

Beta

0.39

Average Sales Estimate Current Quarter

905

Average Sales Estimate Next Quarter

742

Fair Value

48.07

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-0.2

Max Drawdown 5-Year %

-43.4

Target Price

52.43

P/E

26.94

Forward P/E

9.13

PEG

1.14

P/S

11.64

P/B

3.17

P/Free Cash Flow

10.66

EPS

1.78

Average EPS Est. Cur. Y

5.06

EPS Next Y. (Est.)

5.45

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.41

Relative Volume

0.92

Return on Equity vs Sector %

-15.5

Return on Equity vs Industry %

0.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.06

EBIT Estimation

176.9

◆ RPRX Healthcare

$47.97

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

6/25

Volume

7/15

Valuation

7/20

TP/AR

4/10

Options

7/10

RSI

67.3

Range 1M

94.6%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

10/30

Estimates

7/20

Inst/Vol

9/15

Options

9/10

EPS Yr

0.5%

EPS NY

8.2%

52W%

99.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +76.9% upside

Quality

6/30

Valuation

17/30

Growth

8/25

Stability

6/10

LT Trend

4/5

Upside

+76.9%

Quality

MoS

Royalty Pharma plc

Sector: Healthcare

Industry: Biotechnology

Employees: 100

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

RPRX

Latest News

—

Caricamento notizie per RPRX…

stock quote shares RPRX – Royalty Pharma plc Stock Price stock today

news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025

marketwatch RPRX – Royalty Pharma plc yahoo finance google finance

stock history RPRX – Royalty Pharma plc invest stock market

stock prices RPRX premarket after hours

ticker RPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y